Grigory Efimov MD, PhD

Grigory Efimov is a Senior Scientific Director at Miltenyi Biotec. He is the Principal investigator in translational immunology with a focus on T-cell therapy of hematological malignancies and viral infections. Currently leading a team of 25+ researchers working on multiple translational and fundamental projects in T-cell immunology. Demonstrated history in the development and commercialization of the in-vitro diagnostic tests for COVID-19 humoral and cellular immune response.